Increased Fibroblast Growth Factor 21 in Nonalcoholic Fatty Liver Disease

被引：0
|
作者：
Dushay, Jody
Chui, Patricia
Gopalakrishnan, Gosala S.
Varelarey, Marta
Crawley, Meghan
Fisher, Ffolliott M.
Badman, Michael K.
Martinez-Chantar, Maria L.
Maratos-Flier, Eleftheria
机构：
来源：
DIABETES | 2010年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A414 / A414
页数：1
相关论文
共 50 条
  • [11] Fibroblast growth factor 21 in non-alcoholic fatty liver disease
    Tucker, Bradley
    Li, Huating
    Long, Xiaoxue
    Rye, Kerry-Anne
    Ong, Kwok Leung
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2019, 101
  • [12] Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges
    Tian, Haoyu
    Zhang, Shuairan
    Liu, Ying
    Wu, Yifan
    Zhang, Dianbao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [13] Association between Serum Atypical Fibroblast Growth Factors 21 and 19 and Pediatric Nonalcoholic Fatty Liver Disease
    Alisi, Anna
    Ceccarelli, Sara
    Panera, Nadia
    Prono, Federica
    Petrini, Stefania
    De Stefanis, Cristiano
    Pezzullo, Marco
    Tozzi, Alberto
    Villani, Alberto
    Bedogni, Giorgio
    Nobili, Valerio
    PLOS ONE, 2013, 8 (06):
  • [14] Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease
    Su, Xin
    Kong, Yi
    Peng, Daoquan
    CLINICA CHIMICA ACTA, 2019, 498 : 30 - 37
  • [15] Serum Fibroblast Growth Factor-21 Is Related to Atherosclerosis Independent of Nonalcoholic Fatty Liver Disease and Predicts Incident Atherosclerotic Cardiovascular Diseases
    Wu, Liang
    Qian, Lingling
    Li, Huating
    Jia, Weiping
    DIABETES, 2018, 67
  • [16] Effective treatment of steatosis and steatohepatitis by fibroblast growth factor 1 in mouse models of nonalcoholic fatty liver disease
    Liu, Weilin
    Struik, Dicky
    Nies, Vera J. M.
    Jurdzinski, Angelika
    Harkema, Liesbeth
    de Bruin, Alain
    Verkade, Henkjan J.
    Downes, Michael
    Evans, Ronald M.
    van Zutphen, Tim
    Jonker, Johan W.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (08) : 2288 - 2293
  • [17] Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease A retrospective clinical study
    Takahashi, Atsushi
    Abe, Kazumichi
    Fujita, Masashi
    Hayashi, Manabu
    Okai, Ken
    Ohira, Hiromasa
    MEDICINE, 2020, 99 (22) : E20399
  • [18] A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver Disease
    Woolsey, Sarah J.
    Beaton, Melanie D.
    Mansell, Sara E.
    Leon-Ponte, Matilde
    Yu, Janice
    Pin, Christopher L.
    Adams, Paul C.
    Kim, Richard B.
    Tirona, Rommel G.
    MOLECULAR PHARMACOLOGY, 2016, 90 (04) : 437 - 446
  • [19] Fibroblast Growth Factor 21 (FGF-21) and Its Relation to Obesity, Metabolic Syndrome, and Nonalcoholic Fatty Liver in Children: A Longitudinal Analysis
    Reinehr, Thomas
    Woelfle, Joachim
    Wunsch, Rainer
    Roth, Christian L.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (06): : 2143 - 2150
  • [20] Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease
    Karamfilova, Vera
    Assyov, Yavor
    Nedeva, Iveta
    Gateva, Antoaneta
    Ivanova, Irena
    Cherkezov, Ivanova
    Mateva, Ludmila
    Kamenov, Zdravko
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (03): : 233 - 239
12345